|
|
Previous Article | Table of Contents | Next Article 
The B7-2 (B70) costimulatory molecule expressed by monocytes and activated
B lymphocytes is the CD86 differentiation antigen
P Engel, JG Gribben, GJ Freeman, LJ Zhou, Y Nozawa, M Abe, LM Nadler, H Wakasa and TF Tedder
Department of Immunology, Duke University Medical Center, Durham, NC 27710.
T-cell activation is initiated after T-cell receptor binding to antigen,
but also requires interactions between costimulatory molecules expressed on
antigen-presenting cells. An important costimulatory molecule expressed by
monocytes and activated B lymphocytes has been recently identified and
termed B7-2 or B70. Independently, a new Cluster of Differentiation was
defined in the Fifth International Leukocyte Differentiation Antigen
Workshop as CD86, a molecule predominantly expressed by monocytes and
activated B lymphocytes. In this study, the two monoclonal antibodies that
defined CD86, FUN-1 and BU-63, were shown to bind to cDNA transfected cells
expressing B7- 2/B70. The FUN-1 monoclonal antibody also completely blocked
the costimulatory activity of B7-2/B70 in functional assays. Therefore, the
serologically defined CD86 differentiation antigen is the B7-2/B70
molecule.
Volume 84,
Issue 5,
pp. 1402-1407,
09/01/1994
Copyright © 1994 by The American Society of Hematology

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. Roy, G. Martin, J.-F. Giguere, D. Belanger, M. Petrin, and M. J. Tremblay
HIV Type 1 Can Act as an APC upon Acquisition from the Host Cell of Peptide-Loaded HLA-DR and CD86 Molecules
J. Immunol.,
April 15, 2005;
174(8):
4779 - 4788.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-F. Giguere, S. Bounou, J.-S. Paquette, J. Madrenas, and M. J. Tremblay
Insertion of Host-Derived Costimulatory Molecules CD80 (B7.1) and CD86 (B7.2) into Human Immunodeficiency Virus Type 1 Affects the Virus Life Cycle
J. Virol.,
June 15, 2004;
78(12):
6222 - 6232.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-F. Giguere, J.-S. Paquette, S. Bounou, R. Cantin, and M. J. Tremblay
New Insights into the Functionality of a Virion-Anchored Host Cell Membrane Protein: CD28 Versus HIV Type 1
J. Immunol.,
September 1, 2002;
169(5):
2762 - 2771.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Ohnuma, Y. Munakata, T. Ishii, S. Iwata, S. Kobayashi, O. Hosono, H. Kawasaki, N. H. Dang, and C. Morimoto
Soluble CD26/Dipeptidyl Peptidase IV Induces T Cell Proliferation Through CD86 Up-Regulation on APCs
J. Immunol.,
December 15, 2001;
167(12):
6745 - 6755.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Krishnan, V. G. Warke, M. P. Nambiar, H. K. Wong, G. C. Tsokos, and D. L. Farber
Generation and biochemical analysis of human effector CD4 T cells: alterations in tyrosine phosphorylation and loss of CD3{zeta} expression
Blood,
June 15, 2001;
97(12):
3851 - 3859.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. F. Jorgensen, J. E. Wang, M. Almlof, C. Thiemermann, S. J. Foster, R. Solberg, and A. O. Aasen
Peptidoglycan and Lipoteichoic Acid Modify Monocyte Phenotype in Human Whole Blood
Clin. Vaccine Immunol.,
May 1, 2001;
8(3):
515 - 521.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. R. Abrams, S. L. Kelley, E. Hayes, T. Kikuchi, M. J. Brown, S. Kang, M. G. Lebwohl, C. A. Guzzo, B. V. Jegasothy, P. S. Linsley, et al.
Blockade of T Lymphocyte Costimulation with Cytotoxic T Lymphocyte-associated Antigen 4-Immunoglobulin (CTLA4Ig) Reverses the Cellular Pathology of Psoriatic Plaques, Including the Activation of Keratinocytes, Dendritic Cells, and Endothelial Cells
J. Exp. Med.,
September 5, 2000;
192(5):
681 - 694.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Smythe, P. D. Fink, G. J. Logan, J. Lees, P. B. Rowe, and I. E. Alexander
Human Fibroblasts Transduced with CD80 or CD86 Efficiently trans-Costimulate CD4+ and CD8+ T Lymphocytes in HLA-Restricted Reactions: Implications for Immune Augmentation Cancer Therapy and Autoimmunity
J. Immunol.,
September 15, 1999;
163(6):
3239 - 3249.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. J. Freeman, A. A. Cardoso, V. A. Boussiotis, A. Anumanthan, R. W. Groves, T. S. Kupper, E. A. Clark, and L. M. Nadler
The BB1 Monoclonal Antibody Recognizes Both Cell Surface CD74 (MHC Class II-Associated Invariant Chain) as Well as B7-1 (CD80), Resolving the Question Regarding a Third CD28/CTLA-4 Counterreceptor
J. Immunol.,
September 15, 1998;
161(6):
2708 - 2715.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Smyth, G. Logan, R. P. Weinberger, P. B. Rowe, I. E. Alexander, and J. A. Smythe
Identification of a Dynamic Intracellular Reservoir of CD86 Protein in Peripheral Blood Monocytes That Is Not Associated with the Golgi Complex
J. Immunol.,
June 1, 1998;
160(11):
5390 - 5396.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Jeannin, Y. Delneste, S. Lecoanet-Henchoz, J.-F. Gauchat, J. Ellis, and J.-Y. Bonnefoy
CD86 (B7-2) on Human B Cells. A FUNCTIONAL ROLE IN PROLIFERATION AND SELECTIVE DIFFERENTIATION INTO IgE- AND IgG4-PRODUCING CELLS
J. Biol. Chem.,
June 20, 1997;
272(25):
15613 - 15619.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Nunès, A. Truneh, D. Olive, and D. A. Cantrell
Signal Transduction by CD28 Costimulatory Receptor on T Cells
J. Biol. Chem.,
January 19, 1996;
271(3):
1591 - 1598.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Bounou, N. Dumais, and M. J. Tremblay
Attachment of Human Immunodeficiency Virus-1 (HIV-1) Particles Bearing Host-encoded B7-2 Proteins Leads to Nuclear Factor-kappa B- and Nuclear Factor of Activated T Cells-dependent Activation of HIV-1 Long Terminal Repeat Transcription
J. Biol. Chem.,
February 23, 2001;
276(9):
6359 - 6369.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|